Risk factors for bleeding in hepatocellular adenoma

被引:74
|
作者
Bieze, M. [1 ]
Phoa, S. S. K. S. [2 ]
Verheij, J. [3 ]
van Lienden, K. P. [4 ]
van Gulik, T. M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Intervent Radiol, NL-1105 AZ Amsterdam, Netherlands
关键词
MCGILL PAIN QUESTIONNAIRE; FOCAL NODULAR HYPERPLASIA; BENIGN HEPATIC-TUMORS; MALIGNANT-TRANSFORMATION; LIVER;
D O I
10.1002/bjs.9493
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hepatocellular adenoma (HCA) is a benign hepatic lesion that may be complicated by bleeding, although the risk of bleeding is ill-defined. The aim of this study was to assess risk factors for bleeding in patients diagnosed with HCA. Methods: Patients with HCA were included prospectively from January 2008 to July 2012. Patient characteristics were noted. Patients underwent dynamic magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation and during follow-up. Lesion characteristics on (follow-up) imaging were noted, and bleeding was graded as intratumoral (grade I), intrahepatic (grade II) or extrahepatic (grade III). The standard of reference for diagnosis was histopathology, or dynamic MRI and/or CT findings. Possible risk factors were included if mentioned in literature (lesion size, body mass index), or based on clinical experience (lesion location, visible vessels on imaging). Results: A total of 45 patients (median age 39 (range 22-60) years; 44 women) with 195 lesions (median size 24 (10-250) mm) were evaluated. Bleeding occurred in 29 patients (64 per cent) and in 42 lesions (21.5 per cent) with a median size of 62 (10-160) mm. Size was a risk factor for bleeding (P<0.001), with an increased number of bleeding events in lesions of 35mm or more. Exophytic lesions (protruding from liver) had more bleeding (16 of 24, 67 per cent) than intrahepatic (9 of 82, 11 per cent) or subcapsular (17 of 89, 19 per cent) lesions (P < 0.001). Lesions in segments II and III had more bleeds than those in the right liver (11 of 32 versus 31 of 163; P = 0.049), as did lesions in which peripheral or central arteries were visualized on imaging (10 of 13 versus 32 of 182 lesions with no visible vascularization; P < 0.001). Conclusion: Risk factors for bleeding of HCA include diameter of 35mm or more, visualization of lesional arteries, location in the left lateral liver, and exophytic growth.
引用
收藏
页码:847 / 855
页数:9
相关论文
共 50 条
  • [1] Risk factors for bleeding hepatocellular adenoma
    Julien, Celine
    Le Bail, Brigitte
    Balabaud, Charles
    Bioulac-Sage, Paulette
    LIVER INTERNATIONAL, 2022, 42 (04) : 947 - 948
  • [2] Risk factors for bleeding hepatocellular adenoma in a United States cohort
    McDermott, Chelsea
    Ertreo, Marco
    Jha, Reena
    Ko, Jimin
    Fernandez, Stephen
    Desale, Sameer
    Fishbein, Thomas
    Satoskar, Rohit
    Winslow, Emily
    Smith, Coleman
    Hsu, Christine C.
    LIVER INTERNATIONAL, 2022, 42 (01) : 224 - 232
  • [3] Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
    Nault, Jean-Charles
    Couchy, Gabrielle
    Balabaud, Charles
    Morcrette, Guillaume
    Caruso, Stefano
    Blanc, Jean-Frederic
    Bacq, Yannick
    Calderaro, Julien
    Paradis, Valerie
    Ramos, Jeanne
    Scoazec, Jean-Yves
    Gnemmi, Viviane
    Sturm, Nathalie
    Guettier, Catherine
    Fabre, Monique
    Savier, Eric
    Chiche, Laurence
    Labrune, Philippe
    Selves, Janick
    Wendum, Dominique
    Pilati, Camilla
    Laurent, Alexis
    De Muret, Anne
    Le Bail, Brigitte
    Rebouissou, Sandra
    Imbeaud, Sandrine
    Bioulac-Sage, Paulette
    Letouze, Eric
    Zucman-Rossi, Jessica
    GASTROENTEROLOGY, 2017, 152 (04) : 880 - +
  • [4] Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma
    Akanuma, M
    Yoshida, H
    Okamoto, M
    Ogura, K
    Maeda, S
    Hata, Y
    Sato, S
    Shiina, S
    Kawabe, T
    Shiratori, Y
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 1039 - 1044
  • [5] Management and outcome of hepatocellular adenoma with massive bleeding at presentation
    Anne J Klompenhouwer
    Robert A de Man
    Maarten GJ Thomeer
    Jan NM Ijzermans
    World Journal of Gastroenterology, 2017, (25) : 4579 - 4586
  • [6] Management and outcome of hepatocellular adenoma with massive bleeding at presentation
    Klompenhouwer, Anne J.
    de Man, Robert A.
    Thomeer, Maarten G. J.
    Ijzermans, Jan N. M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (25) : 4579 - 4586
  • [7] Argininosuccinate Synthase 1 (ASS1): A Marker of Unclassified Hepatocellular Adenoma and High Bleeding Risk
    Henriet, Elodie
    Abou Hammoud, Aya
    Dupuy, Jean-William
    Dartigues, Benjamin
    Ezzoukry, Zakaria
    Dugot-Senant, Nathalie
    Leste-Lasserre, Thierry
    Pallares-Lupon, Nestor
    Nikolski, Macha
    Le Bail, Brigitte
    Blanc, Jean-Frederic
    Balabaud, Charles
    Bioulac-Sage, Paulette
    Raymond, Anne-Aurelie
    Saltel, Frederic
    HEPATOLOGY, 2017, 66 (06) : 2016 - 2028
  • [8] Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis
    Thevathasan, Tharusan
    Colbatzky, Teresa
    Schmelzle, Moritz
    Pratschke, Johann
    Krenzien, Felix
    BMJ OPEN, 2021, 11 (08):
  • [9] A Multicenter, 10-Year Experience With Hepatocellular Adenoma: Risk Factors and Disease Course
    Silva, Trevor S.
    Sung, Michael
    Nelson, Daniel W.
    DiFronzo, Andrew L.
    O'Connor, Victoria V.
    AMERICAN SURGEON, 2022, 88 (09) : 2345 - 2350
  • [10] Hepatic adenomatosis increases risk of hepatic adenoma bleeding
    Mcdermott, Chelsea
    Hsu, Christine Cho-Shing
    Desale, Sameer
    Fernandez, Stephen
    Ertreo, Marco
    Jha, Reena C.
    Satoskar, Rohit S.
    Lalos, Alexander T.
    Rangnekar, Amol S.
    Thomas, Arul M.
    Smith, Coleman I.
    Faust, Thomas W.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E841 - E841